Good to see the FDA clearing these Apps.
Should be reasonably straight forward as they only want to see it doesn't harm anybody in the main.
Lets hope Akili gets its spac deal done in this recessive environment.
If it does that should represent a massive vote of confidence for Tali and Grays potential view of sale to Akili.
Lets hope everything lines up before easy money runs out.
- Forums
- ASX - By Stock
- TD1
- Ann: Letter to Shareholders
Ann: Letter to Shareholders, page-4
Featured News
Add TD1 (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.001(50.0%) |
Mkt cap ! $4.942M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $270 | 180K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
38 | 48256239 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 52992898 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 48256239 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 52992898 | 21 |
0.003 | 39350277 | 15 |
0.004 | 2320000 | 3 |
0.005 | 4000000 | 1 |
0.006 | 250000 | 1 |
Last trade - 15.06pm 03/07/2024 (20 minute delay) ? |
Featured News
TD1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online